CD63 and lung cancer: Jakobsen et al. developed an EV Array that coupled 37 antibodies targeting lung cancer-associated proteins and a panel of CD9, CD63, and CD81 antibodies to explore circulating EVs from healthy subjects and lung cancer patients.